Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea

PHASE4CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

April 30, 2009

Study Completion Date

July 31, 2009

Conditions
Papulopustular Rosacea
Interventions
DRUG

Azelaic acid (Finacea, BAY39-6251)

Participants received topical azelaic acid gel 15% twice daily for 12 weeks

DRUG

Metronidazole (Metrogel)

Participants received topical metronidazole 1% gel once daily for 12 weeks

DRUG

Doxycycline (Oracea)

Participants received systemic doxycycline 40 mg once daily for 12 week

Trial Locations (17)

11790

Stony Brook

23507

Norfolk

33401

West Palm Beach

35233

Birmingham

45040

Mason

48088

Warren

55432

Fridley

75246

Dallas

77056

Houston

78229

San Antonio

78759

Austin

80209

Denver

84124

Salt Lake City

87106

Albuquerque

89052

Henderson

97223

Portland

02114-2517

Boston

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

LEO Pharma

INDUSTRY

NCT00855595 - Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea | Biotech Hunter | Biotech Hunter